| 000 | 01797 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513142328.0 | ||
| 264 | 0 | _c19980612 | |
| 008 | 199806s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGodwin, J E | |
| 245 | 0 | 0 |
_aA double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). _h[electronic resource] |
| 260 |
_bBlood _cMay 1998 |
||
| 300 |
_a3607-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFilgrastim |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfection Control |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xdrug therapy |
| 650 | 0 | 4 | _aLife Tables |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xprevention & control |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKopecky, K J | |
| 700 | 1 | _aHead, D R | |
| 700 | 1 | _aWillman, C L | |
| 700 | 1 | _aLeith, C P | |
| 700 | 1 | _aHynes, H E | |
| 700 | 1 | _aBalcerzak, S P | |
| 700 | 1 | _aAppelbaum, F R | |
| 773 | 0 |
_tBlood _gvol. 91 _gno. 10 _gp. 3607-15 |
|
| 999 |
_c9540007 _d9540007 |
||